We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $6.44B
1-Year Est. Return 25.27%
This Fund
S&P 500
This Quarter Est. Return
+7.27%
1 Year Est. Return
+25.27%
3 Year Est. Return
+77.25%
5 Year Est. Return
+101.72%
10 Year Est. Return
AUM
$4.76B
AUM Growth
+$561M
Cap. Flow
+$284M
Cap. Flow %
5.97%
Top 10 Hldgs %
29.41%
Holding
449
New
22
Increased
185
Reduced
143
Closed
20

Top Sells

Rank Stock Value
1
SYY icon
Sysco
SYY
+$15M
2
MRK icon
Merck
MRK
+$11.8M
3
B
Barrick Mining
B
+$10.3M
4
BSX icon
Boston Scientific
BSX
+$9.6M
5
NDSN icon
Nordson
NDSN
+$3.7M

Sector Composition

Rank Sector Weight
1 Technology 22.35%
2 Healthcare 16.01%
3 Financials 11.88%
4 Industrials 10.97%
5 Consumer Staples 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
26
SPDR Gold Trust
GLD
$141B
$52.7M 1.11%
295,444
-7,160
-2% -$1.32M
AEM icon
27
Agnico Eagle Mines
AEM
$90.5B
$51.8M 1.09%
1,036,872
+49,885
+5% +$2.7M
NOC icon
28
Northrop Grumman
NOC
$81.2B
$49.9M 1.05%
109,544
-612
-0.6% -$278K
MCD icon
29
McDonald's
MCD
$195B
$49.6M 1.04%
166,346
-170
-0.1% -$49.4K
CVX icon
30
Chevron
CVX
$366B
$48M 1.01%
305,210
+33,269
+12% +$5.33M
ABT icon
31
Abbott
ABT
$187B
$46.2M 0.97%
424,061
+77,222
+22% +$8.23M
MDLZ icon
32
Mondelez International
MDLZ
$79.9B
$44.4M 0.93%
608,706
+38,282
+7% +$2.83M
INTU icon
33
Intuit
INTU
$89B
$44.4M 0.93%
96,896
+15,217
+19% +$6.66M
FTV icon
34
Fortive
FTV
$18.6B
$42.5M 0.89%
754,430
-16,204
-2% -$818K
APH icon
35
Amphenol
APH
$209B
$40.4M 0.85%
951,212
+73,534
+8% +$2.86M
AMAT icon
36
Applied Materials
AMAT
$428B
$38.4M 0.81%
265,783
+257,109
+2,964% +$32.2M
PG icon
37
Procter & Gamble
PG
$339B
$38M 0.8%
250,251
-1,678
-0.7% -$253K
UNP icon
38
Union Pacific
UNP
$174B
$37.8M 0.79%
184,659
-56
-0% -$11.1K
ZTS icon
39
Zoetis
ZTS
$30B
$36.4M 0.77%
211,405
-3,239
-2% -$560K
CSCO icon
40
Cisco
CSCO
$479B
$35.9M 0.75%
693,240
-6,500
-0.9% -$320K
BSX icon
41
Boston Scientific
BSX
$71.5B
$35.7M 0.75%
659,278
-183,886
-22% -$9.6M
FISV
42
Fiserv Inc
FISV
$27.9B
$35M 0.74%
277,537
+33,448
+14% +$3.94M
ABBV icon
43
AbbVie
ABBV
$435B
$34.7M 0.73%
257,531
-263
-0.1% -$38.6K
ADP icon
44
Automatic Data Processing
ADP
$108B
$34.3M 0.72%
156,181
+27,437
+21% +$5.92M
NKE icon
45
Nike
NKE
$61.9B
$33M 0.69%
299,271
+519
+0.2% +$60.7K
LOW icon
46
Lowe's Companies
LOW
$125B
$30.2M 0.63%
133,684
+101
+0.1% +$21K
SPGI icon
47
S&P Global
SPGI
$120B
$30.1M 0.63%
75,010
+13,175
+21% +$4.81M
CAT icon
48
Caterpillar
CAT
$387B
$28.2M 0.59%
114,494
+505
+0.4% +$113K
ENB icon
49
Enbridge
ENB
$112B
$26.9M 0.57%
724,910
-40,697
-5% -$1.55M
MKC icon
50
McCormick & Company Non-Voting
MKC
$14.2B
$26.9M 0.56%
307,966
-14,557
-5% -$1.29M

Similar funds

Bradley Foster & Sargent's Q2 2023 Portfolio in Review

As of Q2 2023, Bradley Foster & Sargent held 449 positions worth $4.76B, up 13% from $4.19B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bradley Foster & Sargent deployed $284M of net new capital in Q2 2023, opening 22 new positions and adding to 185 existing holdings. Its largest new stake was Labcorp: 34,403 shares worth $7.13M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Sysco, an estimated $15M trimmed.

  • Bradley Foster & Sargent's largest Q2 2023 buy was Labcorp: 34,403 shares worth $7.13M.
  • Bradley Foster & Sargent added most to Constellation Brands in Q2 2023, an estimated $38.7M increase.
  • Bradley Foster & Sargent's biggest Q2 2023 reduction was Sysco, cutting an estimated $15M.
  • Bradley Foster & Sargent fully exited Matador Resources in Q2 2023, selling an estimated $1.61M.
  • Bradley Foster & Sargent's ten largest holdings make up 29% of its $4.76B portfolio in Q2 2023.
  • Bradley Foster & Sargent opened 22 new positions and closed 20 in Q2 2023.
  • Bradley Foster & Sargent's portfolio value rose 13% quarter-over-quarter to $4.76B.

Based on Bradley Foster & Sargent's 13F filing for Q2 2023, filed 8 Aug 2023.